{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:42:02Z","timestamp":1787740922779,"version":"build-2784847793"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Research Foundation (NRF) of South Africa","award":["TTK13020718661"],"award-info":[{"award-number":["TTK13020718661"]}]},{"name":"Centre of Excellence for Pharmaceutical Sciences"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.ejpb.2017.01.006","type":"journal-article","created":{"date-parts":[[2017,1,22]],"date-time":"2017-01-22T14:00:34Z","timestamp":1485093634000},"page":"96-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Topical delivery of roxithromycin solid-state forms entrapped in vesicles"],"prefix":"10.1016","volume":"114","author":[{"given":"Candice","family":"Csongradi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanetta","family":"du Plessis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marique Elizabeth","family":"Aucamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minja","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejpb.2017.01.006_b0005","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1067\/mjd.2003.618","article-title":"Management of acne: a report from a global alliance to improve outcomes in acne","volume":"49","author":"Gollnick","year":"2003","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejpb.2017.01.006_b0010","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0140-6736(11)60321-8","article-title":"Acne vulgaris","volume":"379","author":"Williams","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ejpb.2017.01.006_b0015","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/j.1610-0387.2006.06053.x","article-title":"Systemic antibiotic therapy for acne vulgaris","volume":"4","author":"Oschsendorf","year":"2006","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"10.1016\/j.ejpb.2017.01.006_b0020","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.2042-7158.1998.tb06193.x","article-title":"Metabolism of roxithromycin in the isolated perfused rat liver","volume":"50","author":"Jarukamjorn","year":"1998","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2017.01.006_b0025","series-title":"Goodman & Gilman's. The Pharmacological Basis of Therapeutics","article-title":"Protein synthesis inhibitors and miscellaneous antibacterial agents","author":"MacDougall","year":"2014"},{"key":"10.1016\/j.ejpb.2017.01.006_b0030","unstructured":"Actavis New Zealand Ltd. Arrow \u2013 Roxithromycin data sheet. Medsafe: New Zealand\u2019s medicine and medical devices safety authority; 2016 February 25. Available from: <http:\/\/www.medsafe.govt.nz\/profs\/datasheet\/a\/ArrowRoxithromycintab.pdf>."},{"issue":"15","key":"10.1016\/j.ejpb.2017.01.006_b0035","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.2165\/00003495-200363150-00005","article-title":"Current concepts of the pathogenesis of acne, implications for drug treatment","volume":"63","author":"Gollnick","year":"2003","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.ejpb.2017.01.006_b0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(02)00121-7","article-title":"New insights into skin structure: scratching the surface","volume":"54","author":"Menon","year":"2002","journal-title":"Adv. Drug. Deliv. Rev."},{"issue":"1","key":"10.1016\/j.ejpb.2017.01.006_b0045","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.2042-7158.1956.tb12194.x","article-title":"Percutaneous absorption","volume":"8","author":"Hadgraft","year":"1956","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2017.01.006_b0050","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijpharm.2013.03.048","article-title":"Solution-mediated phase transformation of different roxithromycin solid-state forms: implications on dissolution and solubility","volume":"449","author":"Aucamp","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2017.01.006_b0055","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1461-5347(00)00295-9","article-title":"Transdermal drug delivery: overcoming the skin\u2019s barrier function","volume":"3","author":"Naik","year":"2000","journal-title":"Pharm. Sci. Tech. Today"},{"key":"10.1016\/j.ejpb.2017.01.006_b0060","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.powtec.2006.07.016","article-title":"A comparative study of approaches used to improve solubility of roxithromycin","volume":"169","author":"Biradar","year":"2006","journal-title":"Powder Technol."},{"issue":"9","key":"10.1016\/j.ejpb.2017.01.006_b0065","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1007\/s12045-009-0084-7","article-title":"Polymorphism: an overview","volume":"14","author":"Purohit","year":"2009","journal-title":"Resonance"},{"key":"10.1016\/j.ejpb.2017.01.006_b0070","unstructured":"W. Liebenberg, M. Aucamp, M.M. De Villiers, Composition comprising an amorphous non-crystalline glass form of roxithromycin, 2013 (Patent: US 20130045936A1)."},{"key":"10.1016\/j.ejpb.2017.01.006_b0075","unstructured":"Liebenberg W, Aucamp M. Amorphous roxithromycin composition. 2013 (Patent: US 20130102550A1)."},{"issue":"3","key":"10.1016\/j.ejpb.2017.01.006_b0080","first-page":"704","article-title":"A comparative review on vesicular drug delivery systems and stability issues","volume":"2","author":"Bansal","year":"2012","journal-title":"Int. J. Res. Pharm. Chem."},{"key":"10.1016\/j.ejpb.2017.01.006_b0085","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jconrel.2012.09.017","article-title":"Approaches for breaking the barriers of drug permeation through transdermal drug delivery","volume":"164","author":"Alexander","year":"2012","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejpb.2017.01.006_b0090","series-title":"Transdermal and Topical Drug Delivery: From Theory to Clinical Practice","author":"Williams","year":"2003"},{"key":"10.1016\/j.ejpb.2017.01.006_b0095","series-title":"Recent Advances in Novel Drug Carrier Systems","first-page":"201","article-title":"Nanocarrier systems for transdermal drug delivery","author":"Escobar-Ch\u00e1vez","year":"2012"},{"key":"10.1016\/j.ejpb.2017.01.006_b0100","unstructured":"D.S. Wishart, Roxithromycin. Drugbank. Available from: <http:\/\/www.drugbank.ca\/drugs\/DB00778> (2016 February 25)."},{"key":"10.1016\/j.ejpb.2017.01.006_b0105","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cocis.2007.05.005","article-title":"Fatty acid vesicles","volume":"12","author":"Morigaki","year":"2007","journal-title":"Curr. Opin. Colloid Interface Sci."},{"issue":"4","key":"10.1016\/j.ejpb.2017.01.006_b0110","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.apsb.2011.09.002","article-title":"Nonionic surfactant vesicular systems for effective drug delivery \u2013 an overview","volume":"1","author":"Kumar","year":"2011","journal-title":"Acta Pharm. Sin. B"},{"issue":"12","key":"10.1016\/j.ejpb.2017.01.006_b0115","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1461-5347(00)00317-5","article-title":"Non-invasive administration of drugs through the skin: challenges in delivery system design","volume":"3","author":"Foldvari","year":"2000","journal-title":"Pharm. Sci. Tech. Today"},{"issue":"16","key":"10.1016\/j.ejpb.2017.01.006_b0120","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S1359-6446(04)03180-0","article-title":"The transdermal revolution","volume":"9","author":"Thomas","year":"2004","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejpb.2017.01.006_b0125","series-title":"Physiological Pharmaceutics: Barriers to Drug Absorption","author":"Washington","year":"2001"},{"key":"10.1016\/j.ejpb.2017.01.006_b0130","article-title":"A novel RP-HPLC method for the detection and quantification of roxithromycin in topical delivery studies","author":"Aucamp","year":"2016","journal-title":"Pharmazie"},{"issue":"2","key":"10.1016\/j.ejpb.2017.01.006_b0135","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1208\/s12249-012-9766-7","article-title":"Physicochemical properties of amorphous roxithromycin prepared by quench cooling of the melt or desolvation of a chloroform solvate","volume":"13","author":"Aucamp","year":"2012","journal-title":"AAPS PharmSciTech."},{"key":"10.1016\/j.ejpb.2017.01.006_b0140","series-title":"Liposomes: A Practical Approach","author":"New","year":"1990"},{"key":"10.1016\/j.ejpb.2017.01.006_b0145","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijpharm.2010.11.003","article-title":"Proniosomes as carrier system for transdermal delivery of tenoxicam","volume":"405","author":"Ammar","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2017.01.006_b0150","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0378-5173(01)00810-9","article-title":"Preparation and in vitro evaluation of liposomal\/niosomal delivery systems for antipsoriatic drug dithranol","volume":"228","author":"Agarwal","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.ejpb.2017.01.006_b0155","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1208\/s12249-009-9325-z","article-title":"Enhanced oral bioavailability of griseofulvin via niosomes","volume":"10","author":"Jadon","year":"2009","journal-title":"AAPS PharmSciTech."},{"key":"10.1016\/j.ejpb.2017.01.006_b0160","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cis.2012.08.002","article-title":"Niosomes: novel sustained release nonionic stable vesicular systems - an overview","volume":"183\u2013184","author":"Mahale","year":"2012","journal-title":"Adv. Colloid Interface"},{"issue":"1","key":"10.1016\/j.ejpb.2017.01.006_b0165","doi-asserted-by":"crossref","first-page":"35","DOI":"10.25004\/IJPSDR.2012.040107","article-title":"Formulation and evaluation of prednisolone proliposomal gel for effective topical pharmacotherapy","volume":"4","author":"Kurakula","year":"2012","journal-title":"Int. J. Pharma. Sci. Drug Res."},{"issue":"10","key":"10.1016\/j.ejpb.2017.01.006_b0170","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1517\/17425255.2013.816284","article-title":"Reconstructed skin models as emerging tools for drug absorption studies","volume":"9","author":"K\u00fcchler","year":"2013","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.ejpb.2017.01.006_b0175","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0378-5173(97)04897-7","article-title":"Supersaturated solutions evaluated with an in vitro stratum corneum tape stripping technique","volume":"151","author":"Pellet","year":"1997","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2017.01.006_b0180","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1159\/000330385","article-title":"Topical and transdermal delivery of L-carnitine","volume":"24","author":"Fox","year":"2011","journal-title":"Skin Pharmacol. Physiol."},{"issue":"6","key":"10.1016\/j.ejpb.2017.01.006_b0185","first-page":"67","article-title":"Pathways for skin penetration","volume":"120","author":"Dayan","year":"2005","journal-title":"Cosmet. Toiletries"},{"key":"10.1016\/j.ejpb.2017.01.006_b0190","unstructured":"Chemical book. Sodium oleate. Available from: <http:\/\/www.chemicalbook.com\/ChemicalProductProperty_EN_CB6726306.htm> (2016 February 25)."},{"key":"10.1016\/j.ejpb.2017.01.006_b0195","series-title":"Handbook of Pharmaceutical Excipients","author":"Row","year":"2009"},{"key":"10.1016\/j.ejpb.2017.01.006_b0200","unstructured":"Aadi Infotech. Sodium oleate. Acme synthetic chemicals. Available from: <http:\/\/www.acmechem.com\/index.php\/2013-09-02-13-05-56\/fatty-acid-salts?layout=edit&id=53> (2016 February 25)."},{"issue":"10","key":"10.1016\/j.ejpb.2017.01.006_b0205","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1023\/B:PHAM.0000045239.22049.70","article-title":"Amphiphilogels for drug delivery: formulation and characterisation","volume":"21","author":"Jibry","year":"2004","journal-title":"Pharm. Res."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641117301042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641117301042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T18:24:07Z","timestamp":1749925447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641117301042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":41,"alternative-id":["S0939641117301042"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2017.01.006","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical delivery of roxithromycin solid-state forms entrapped in vesicles","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2017.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}